ImageneBio Inc
54 hedge funds and large institutions have $63.9M invested in ImageneBio Inc in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 8 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 12
0.62% less ownership
Funds ownership: 6.22% → 5.6% (-0.62%)
7% less funds holding
Funds holding: 58 → 54 (-4)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
55% less capital invested
Capital invested by funds: $142M → $63.9M (-$77.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOCH
Blue Owl Capital Holdings
New York
|
+$5.31M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$4.35M |
| 3 |
BlackRock
New York
|
+$1.12M |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$1.06M |
| 5 |
O
OrbiMed
New York
|
+$960K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$7.1M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.39M |
| 3 |
AG
Artal Group
Luxembourg
|
-$2.31M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.08M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$744K |
IMA Hedge Fund Activity: Q4 2023 in Review
54 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q4 2023, worth a combined $63.9M — down 55% from $142M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IMA and 6 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 28 added.
The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $5.31M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $7.1M sold.
- 54 institutional investors held ImageneBio Inc (IMA) as of Q4 2023, down from 58 in Q3 2023.
- Funds reported $63.9M of ImageneBio Inc stock for Q4 2023, down 55% quarter-over-quarter.
- 6 funds opened new ImageneBio Inc positions in Q4 2023 and 8 closed out, a net change of -2 holders.
- The largest ImageneBio Inc buyer in Q4 2023 was Blue Owl Capital Holdings, an estimated $5.31M added.
- The largest ImageneBio Inc seller in Q4 2023 was Avoro Capital Advisors, an estimated $7.1M sold.
Based on aggregated 13F filings for Q4 2023.